NCT02609139 - Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Healthy

Interventions

DRUG

PF-06650833

Up to 400mg modified release tablets administered under fasted conditions

DRUG

PF-06650833

100mg modified release tablet administered under fasted conditions

DRUG

PF-06650833

20mg modified release tablet administered under fasted conditions

DRUG

PF-06650833

Up to 400mg modified release tablets administered with high fat meal food intake

DRUG

PF-06650833

100mg modified released tablet administered with high fat meal food intake

DRUG

PF-06650833

20 mg modified release tablet administered with high fat meal food intake

Trial Locations (1)

New Haven Clinical Research Unit, New Haven